Dépression (psychiatrie) (French Wikipedia)

(en) Salvador Z Kempton MJ, « Structural Neuroimaging Studies in Major Depressive Disorder: Meta-analysis and Comparison With Bipolar Disorder », Arch Gen Psychiatry, vol. 68, n^o 7,‎ 2011, p. 675–690 (DOI 10.1001/archgenpsychiatry.2011.60, lire en ligne).
(en) Marquand AF et Hahn T, « Integrating Neurobiological Markers of Depression », Arch. Gen. Psychiatry, vol. 68, n^o 4,‎ décembre 2010, p. 361–368 (DOI 10.1001/archgenpsychiatry.2010.178, lire en ligne).
(en) Schmitz MF et Wakefield JC, « Extending the bereavement exclusion for major depression to other losses: Evidence from the National Comorbidity Survey », Archives of General Psychiatry, vol. 64, n^o 4,‎ 2007, p. 433–440 (DOI 10.1001/archpsyc.64.4.433, lire en ligne).

archinte.ama-assn.org

(en) Bair, MJ, Robinson, RL, Katon, W et Kroenke, K., Depression and Pain Comorbidity: A Literature Review, vol. 163, 2003 (PMID 14609780, DOI 10.1001/archinte.163.20.2433, lire en ligne), chap. 20, p. 2433–2445.

jama.ama-assn.org

(en) R. F. Haskett et H. A. Sackeim, « Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial », JAMA: Journal of the American Medical Association, vol. 285, n^o 10,‎ 2001, p. 1299–1307 (DOI 10.1001/jama.285.10.1299, lire en ligne).

archive.is

(en) Slavich GM, « Deconstructing depression: A diathesis-stress perspective »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, APS Observer (consulté le 11 novembre 2008).
(en) Kay Jamison, « Brain Damage in Depression and Bipolar Disorder »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, McMan's Depression and Bipolar Web, 21 janvier 2004.
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
« Thérapie interpersonnelle dans le traitement de la dépression majeure »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)} [PDF], sur Regroupement.net (consulté le 8 avril 2011).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.

atypon-link.com

(en) F Tilbury, « There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress », Health Sociology Review, vol. 13, n^o 1,‎ 2004, p. 54–64 (DOI 10.5555/hesr.2004.13.1.54, lire en ligne).
(en) F Tilbury, « There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress », Health Sociology Review, vol. 13, n^o 1,‎ 2004, p. 54–64. (PMID 11384889, DOI 10.5555/hesr.2004.13.1.54, lire en ligne)

bbc.co.uk

news.bbc.co.uk

(en) « Call for action over Third World depression », BBC News (Health), 1999 (consulté le 11 octobre 2008).

belgium.be

health.belgium.be

« Le trouble dépressif : prise en charge du patient et usage optimal du système de soins et des orientations thérapeutiques », AVIS DU CONSEIL SUPERIEUR DE LA SANTE n^o 8155, Conseil Supérieur de la Santé, décembre 2013 (consulté le 4 mars 2014).

benzo.org.uk

(en) Professeur Heather Ashton, « Benzodiazepines: How They Work and How to Withdraw ».

blackdoginstitute.org.au

(en) « Churchill’s Black Dog?: The History of the ‘Black Dog’ as a Metaphor for Depression », Black Dog Institute website (consulté le 18 août 2008).

bmj.com

(en) Abas M Patel V, « Depression in developing countries: Lessons from Zimbabwe », BMJ, vol. 322, n^o 7284,‎ 2001, p. 482–484 (DOI 10.1136/bmj.322.7284.482, <span%20class= "lang-en"%20lang="en">fulltext) lire en ligne)
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
(en) P Stallard, K Sayal, R Phillips, JA Taylor, M Spears, R Anderson, R Araya, G Lewis et A Millings, « Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: Pragmatic cluster randomised controlled trial », BMJ (Clinical research ed.), vol. 345,‎ 2012, e6058 (PMID 23043090, PMCID 3465253, DOI 10.1136/bmj.e6058, lire en ligne).
Amick HR, Gartlehner G, Gaynes BN et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis, BMJ, 2015;351:h6019
(en) Gordon Parker, « Is depression overdiagnosed? Yes », BMJ, vol. 335, n^o 7615,‎ 2007, p. 328 (DOI 10.1136/bmj.39268.475799.AD, lire en ligne).

ebmh.bmj.com

(en) Weersing, VR et Walker, PN, « Review: Cognitive behavioural therapy for adolescents with depression », Evidence-Based Mental Health, vol. 11, n^o 3,‎ 2008, p. 76 (PMID 18669678, DOI 10.1136/ebmh.11.3.76, lire en ligne, consulté le 28 novembre 2008).

jnnp.bmj.com

(en) Rickards H, « Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke », Journal of Neurology Neurosurgery and Psychiatry, vol. 76,‎ 2005, i48–i52 (DOI 10.1136/jnnp.2004.060426, lire en ligne).

books.google.com

(en) Semple, David, Oxford Handbook of Psychiatry, Royaume-Uni, Oxford University Press, 2007, 953 p. (ISBN 978-0-19-852783-1 et 0-19-852783-7, lire en ligne), chap. 13, p. 540.
(en) David Healy, The Antidepressant Era, Cambridge, MA, Harvard University Press, 1999, 317 p. (ISBN 0-674-03958-0, lire en ligne), p. 42.
(en) Miranda Seymour, Mary Shelley, Grove Press, 2002, 655 p. (ISBN 0-8021-3948-5, lire en ligne), p. 560–561.

co-psychiatry.com

(en) Monteleone P, « Endocrine disturbances and psychiatric disorders », Current Opinion in Psychiatry, Lippincott Williams & Wilkins, Inc., vol. 14, n^o 6,‎ 2001, p. 605–610 (lire en ligne)

cochrane.org

(en) House AO, Gilbody S et TA Sheldon, « Screening and case finding instruments for depression », Cochrane Database of Systematic Reviews, n^o 4,‎ 2005, p. CD002792 (DOI 10.1002/14651858.CD002792.pub2, lire en ligne).

compasspathways.com

(en-US) « COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression – COMPASS » (consulté le 12 décembre 2018)

doctissimo.fr

Autorisation de mise sur le marché pour un extrait de millepertuis

doi.org

dx.doi.org

(en) Caspi A, Sugden K, Moffitt TE, « Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene », Science, vol. 301, n^o 5631,‎ 2003, p. 386–389 (PMID 12869766, DOI 10.1126/science.1083968, Bibcode 2003Sci...301..386C).
(en) Gatz M Kendler KS, « A Swedish national twin study of lifetime major depression », American Journal of Psychiatry, vol. 163, n^o 1,‎ 2006, p. 109–114 (DOI 10.1176/appi.ajp.163.1.109).
Thomas Rabeyron, « Du néolibéralisme au Tsunami Cognitivo-Comportemental en Grande-Bretagne : Est-il encore temps pour la France d’éviter la catastrophe britannique ? », Research in Psychoanalysis, vol. N°28, n^o 2,‎ 2019, p. 118 (DOI 10.3917/rep1.028.0112)
(en) Nestler EJ et Krishnan V, « The molecular neurobiology of depression », Nature, vol. 455, n^o 7215,‎ octobre 2008, p. 894–902 (DOI 10.1038/nature07455).
(en) Sugden K et Caspi A, « Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene », Science, vol. 301, n^o 5631,‎ juillet 2003, p. 386–389 (PMID 12869766, DOI 10.1126/science.1083968).
(en) Herrell R et Risch N, « Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis », JAMA, vol. 301, n^o 23,‎ juin 2009, p. 2462–2471 (DOI 10.1001/jama.2009.878).
(en) Durrant C et Munafò MR, « Gene X environment interactions at the serotonin transporter locus », Biol. Psychiatry, vol. 65, n^o 3,‎ février 2009, p. 211–219. (PMID 18691701, DOI 10.1016/j.biopsych.2008.06.009).
(en) McGuffin P et Uher R, « The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update », Mol. Psychiatry, vol. 15, n^o 1,‎ janvier 2010, p. 18–22 (PMID 20029411, DOI 10.1038/mp.2009.123).
(en) Salvador Z Kempton MJ, « Structural Neuroimaging Studies in Major Depressive Disorder: Meta-analysis and Comparison With Bipolar Disorder », Arch Gen Psychiatry, vol. 68, n^o 7,‎ 2011, p. 675–690 (DOI 10.1001/archgenpsychiatry.2011.60, lire en ligne).
(en) McIntosh AM Arnone D, « Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses », Eur Neuropsychopharmacol, vol. 22, n^o 1,‎ juillet 2011, p. 1–16 (DOI 10.1016/j.euroneuro.2011.05.003).
(en) Le Masurier M Herrmann LL, « White matter hyperintensities in late life depression: a systematic review », Journal of Neurology, Neurosurgery, and Psychiatry, vol. 79, n^o 6,‎ 2008, p. 619–624 (PMID 17717021, DOI 10.1136/jnnp.2007.124651).
(en) Gado MH Sheline YI, « Untreated depression and hippocampal volume loss », American Journal of Psychiatry, vol. 160, n^o 8,‎ 2003, p. 1516–1518 (PMID 12900317, DOI 10.1176/appi.ajp.160.8.1516).
(en) Duman R Sen S, « Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications », Biological Psychiatry, vol. 64, n^o 6,‎ 2008, p. 527–532 (PMID 18571629, PMCID 2597158, DOI 10.1016/j.biopsych.2008.05.005).
(en) O'Connor JC et Dantzer R, « From inflammation to sickness and depression: when the immune system subjugates the brain », Nat Rev Neurosci, vol. 9, n^o 1,‎ 2008, p. 46–56 (DOI 10.1038/nrn2297, lire en ligne).
(en) Herrmann N et Dowlati Y, « A meta-analysis of cytokines in major depression », Biological Psychiatry, vol. 67, n^o 5,‎ 2010, p. 446–457 (DOI 10.1016/j.biopsych.2009.09.033).
Müller N, Myint AM, Schwarz MJ, « Inflammatory biomarkers and depression », Neurotox Res, vol. 19, n^o 2,‎ février 2011, p. 308–318 (PMID 20658274, DOI 10.1007/s12640-010-9210-2).
William T. L. Cox, Lyn Y. Abramson, Patricia G. Devine et Steven D. Hollon, « Stereotypes, Prejudice, and Depression: The Integrated Perspective », Perspectives on Psychological Science, vol. 7, n^o 5,‎ 2012, p. 427–449 (DOI 10.1177/1745691612455204, lire en ligne).
(en) Norbury R Cutter WJ, « Oestrogen, brain function, and neuropsychiatric disorders », Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, n^o 7,‎ 2003, p. 837–840 (PMID 12810759, PMCID 1738534, DOI 10.1136/jnnp.74.7.837).
(en) GC Lasiuk et Hegadoren, « The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women », Biological Research for Nursing, vol. 9, n^o 2,‎ 2007, p. 147–160 (PMID 17909167, DOI 10.1177/1099800407305600).
(en) Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M, « Testosterone and depression: systematic review and meta-analysis », J Psychiatr Pract, vol. 15, n^o 4,‎ 2009, p. 289-305. (PMID 19625884, DOI 10.1097/01.pra.0000358315.88931.fc, lire en ligne [html]) modifier
(en) Eleni Siopi et al., « Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine », Cell Reports, vol. 30, n^o 11,‎ 17 mars 2020, p. 3682-3690 (DOI 10.1016/j.celrep.2020.02.099, lire en ligne, consulté le 13 septembre 2021).
(en) Grégoire Chevalier et al., « Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system », Cell Reports,‎ 11 décembre 2020 (DOI 10.1038/s41467-020-19931-2, lire en ligne, consulté le 13 septembre 2021).
Cottencin O, « [Severe depression and addictions] », Encéphale, vol. 35 Suppl 7,‎ décembre 2009, S264–8 (PMID 20141784, DOI 10.1016/S0013-7006(09)73483-9).
(en) Falk DE, Yi HY, Hilton ME, « Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders », Drug Alcohol Depend, vol. 94, n^os 1–3,‎ 2008, p. 234–245 (PMID 18215474, PMCID 2386955, DOI 10.1016/j.drugalcdep.2007.11.022).
(en) Boden JM, Fergusson DM, « Alcohol and depression », Addiction, vol. 106, n^o 5,‎ mai 2011, p. 906–914 (PMID 21382111, DOI 10.1111/j.1360-0443.2010.03351.x).
(en) Kelley KW, Dantzer R, « Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders », Brain Behav. Immun., vol. 25 Suppl 1,‎ juin 2011, S13–20 (PMID 21193024, DOI 10.1016/j.bbi.2010.12.013).
(en) Riss, J., Cloyd, J., Gates, J. et Collins, S., « Benzodiazepines in epilepsy: pharmacology and pharmacokinetics », Acta Neurol Scand, vol. 118, n^o 2,‎ 2008, p. 69–86 (PMID 18384456, DOI 10.1111/j.1600-0404.2008.01004.x).
(en) Werb D Marshall BD, « Health outcomes associated with methamphetamine use among young people: a systematic review », Addiction, vol. 105, n^o 6,‎ juin 2010, p. 991–1002 (DOI 10.1111/j.1360-0443.2010.02932.x).
(en) Jeronimus B.F., Kotov, R., Riese, H. et Ormel, J., « Neuroticism's prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: a meta-analysis on 59 longitudinal/prospective studies with 443 313 participants », Psychological Medicine,‎ 2016 (PMID 27523506, DOI 10.1017/S0033291716001653, lire en ligne)
(en) Morris BH, Bylsma LM, Rottenberg J, « Does emotion predict the course of major depressive disorder? A review of prospective studies », Br J Clin Psychol, vol. 48, n^o Pt 3,‎ septembre 2009, p. 255–273 (PMID 19187578, DOI 10.1348/014466508X396549, lire en ligne).
(en) McCullough, Michael; Larson, David, « Religion and depression: a review of the literature », Twin Research, Australian Academic Press, vol. 2, n^o 2,‎ 1^er juin 1999, p. 126–136 (PMID 10480747, DOI 10.1375/136905299320565997, lire en ligne).
(en) Dein, S, « Religion, spirituality and depression: implications for research and treatment », Primary Care and Community Psychiatry, vol. 11, n^o 2,‎ 2006, p. 67–72 (DOI 10.1185/135525706X121110, lire en ligne [PDF], consulté le 21 novembre 2008).
(en) Moreira-Almeida, A., Neto, FL. et Koenig, HG., « Religiousness and mental health: a review », Rev. Bras. Psyquiatr., vol. 28, n^o 3,‎ septembre 2006, p. 242–250 (PMID 16924349, DOI 10.1590/S1516-44462006005000006, lire en ligne).
(en) Hinrichsen GA, Emery EE, « Interpersonal factors and late-life depression », Clinical Psychology: Science and Practice, vol. 12, n^o 3,‎ 2006, p. 264–275 (DOI 10.1093/clipsy/bpi027).
(en) Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D, « Mourning and melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry », Annals of General Psychiatry, vol. 7,‎ 2008, p. 9 (PMID 18652673, PMCID 2515304, DOI 10.1186/1744-859X-7-9).
(en) J Radden, « Is this dame melancholy?: Equating today's depression and past melancholia », Philosophy, Psychiatry, & Psychology, vol. 10, n^o 1,‎ 2003, p. 37–52 (DOI 10.1353/ppp.2003.0081, lire en ligne).
(en) Newport DJ Heim C, « The link between childhood trauma and depression: insights from HPA axis studies in humans », Psychoneuroendocrinology, vol. 33, n^o 6,‎ 2008, p. 693–710 (PMID 18602762, DOI 10.1016/j.psyneuen.2008.03.008).
(en) RC Kessler, « The effects of stressful life events on depression », Annual revue of Psychology, vol. 48,‎ 1997, p. 191–214 (DOI 10.1146/annurev.psych.48.1.191).
(en) KS Kendler, JM Hettema, F Butera, CO Gardner et CA Prescott, « Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety », Archives of General Psychiatry, vol. 60, n^o 8,‎ 2003, p. 789–796 (DOI 10.1001/archpsyc.60.8.789).
(en) Thornton T Slavich GM, « Targeted rejection predicts hastened onset of major depression », Journal of Social and Clinical Psychology, vol. 28,‎ 2009, p. 223–243 (DOI 10.1521/jscp.2009.28.2.223).
(en) Monroe SM, Slavich GM, Torres LD, Gotlib IH, « Major life events and major chronic difficulties are differentially associated with history of major depressive episodes », Journal of Abnormal Psychology, vol. 116, n^o 1,‎ 2007, p. 116–124 (PMID 17324022, DOI 10.1037/0021-843X.116.1.116).
(en) Vilhjalmsson R, « Life stress, social support and clinical depression: A reanalysis of the literature », Social Science & Medicine, vol. 37, n^o 3,‎ 1993, p. 331–342 (DOI 10.1016/0277-9536(93)90264-5).
(en) D Kim, « Blues from the neighborhood? Neighborhood characteristics and depression », Epidemiologic reviews, vol. 30,‎ 2008, p. 101–117 (DOI 10.1093/epirev/mxn009).
(en) Bonde JP, « Psychosocial factors at work and risk of depression: A systematic review of the epidemiological evidence », Journal of Occupational and Environmental Medicine, vol. 65, n^o 7,‎ 2008, p. 438–445 (DOI 10.1136/oem.2007.038430).
(en) Joaquim Radua, Alberto Pertusa et Narcis Cardoner, « Climatic relationships with specific clinical subtypes of depression », Psychiatry Research, vol. 175, n^o 3,‎ 28 février 2010, p. 217–220 (PMID 20045197, DOI 10.1016/j.psychres.2008.10.025).
Yujie Zhao, Liu Yang, Barbara J. Sahakian et Christelle Langley, « The brain structure, immunometabolic and genetic mechanisms underlying the association between lifestyle and depression », Nature Mental Health, vol. 1, n^o 10,‎ 11 septembre 2023, p. 736–750 (ISSN 2731-6076, DOI 10.1038/s44220-023-00120-1, lire en ligne, consulté le 9 octobre 2023)
(en) Abas M Patel V, « Depression in developing countries: Lessons from Zimbabwe », BMJ, vol. 322, n^o 7284,‎ 2001, p. 482–484 (DOI 10.1136/bmj.322.7284.482, <span%20class= "lang-en"%20lang="en">fulltext) lire en ligne)
(en) M. Zimmerman, I Chelminski et M. Posternak, « A Review of Studies of the Hamilton Depression Rating Scale in Healthy Controls: Implications for the Definition of Remission in Treatment Studies Of Depression », J Nerv Ment Dis, vol. 192, n^o 9,‎ '"`uniq--nowiki-0000051c-qinu`"'.^[quand ?], p. 595–601 (DOI 10.1097/01.nmd.0000138226.22761.39).
(en) A. McPherson et C. R. Martin, « A Narrative Review of the Beck Depression Inventory (BDI) and Implications for its Use in an Alcohol-Dependent Population », J Psychiatr Ment Health Nurs, vol. 17, n^o 1,‎ '"`uniq--nowiki-0000051d-qinu`"'.^[quand ?], p. 19–30 (DOI 10.1111/j.1365-2850.2009.01469.x).
(en) House AO, Gilbody S et TA Sheldon, « Screening and case finding instruments for depression », Cochrane Database of Systematic Reviews, n^o 4,‎ 2005, p. CD002792 (DOI 10.1002/14651858.CD002792.pub2, lire en ligne).
(en) McCusker J et Cepoiu M, « Recognition of depression by non-psychiatric physicians—a systematic literature review and meta-analysis », J Gen Intern Med, vol. 23, n^o 1,‎ 2008, p. 25–36 (DOI 10.1007/s11606-007-0428-5).
(en) Sorour E et Dale J, « Do psychiatrists perform appropriate physical investigations for their patients? A review of current practices in a general psychiatric inpatient and outpatient setting », Journal of Mental Health, vol. 17, n^o 3,‎ 2008, p. 293–298 (DOI 10.1080/09638230701498325).
(en) Maclullich AM et Reid LM, « Subjective memory complaints and cognitive impairment in older people », Dementia and geriatric cognitive disorders, vol. 22, n^os 5–6,‎ 2006, p. 471–485 (PMID 17047326, DOI 10.1159/000096295).
(en) Persad C et Wright SL, « Distinguishing between depression and dementia in older persons: Neuropsychological and neuropathological correlates », Journal of geriatric psychiatry and neurology, vol. 20, n^o 4,‎ 2007, p. 189–198 (DOI 10.1177/0891988707308801).
(en) Marquand AF et Hahn T, « Integrating Neurobiological Markers of Depression », Arch. Gen. Psychiatry, vol. 68, n^o 4,‎ décembre 2010, p. 361–368 (DOI 10.1001/archgenpsychiatry.2010.178, lire en ligne).
(en) Schmitz MF et Wakefield JC, « Extending the bereavement exclusion for major depression to other losses: Evidence from the National Comorbidity Survey », Archives of General Psychiatry, vol. 64, n^o 4,‎ 2007, p. 433–440 (DOI 10.1001/archpsyc.64.4.433, lire en ligne).
(en) Altamura AC, Carta MG, MC Hardoy, F Pinna et S Medda, « Is recurrent brief depression an expression of mood spectrum disorders in young people? », European Archives of Psychiatry and Clinical Neuroscience, vol. 253, n^o 3,‎ 2003, p. 149–153 (DOI 10.1007/s00406-003-0418-5).
(en) Judd LL et Rapaport MH, « A descriptive analysis of minor depression », American Journal of Psychiatry, vol. 159, n^o 4,‎ 2002, p. 637–643 (DOI 10.1176/appi.ajp.159.4.637).
(en) Benazzi F et Akiskal HS, « The DSM-⁵ and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: Evidence that they lie on a dimensional spectrum », Journal of Affective Disorders, vol. 92, n^o 1,‎ 2006, p. 45–54 (PMID 16488021, DOI 10.1016/j.jad.2005.12.035).
(en) Grant BF, « Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults », Journal of Substance Abuse, vol. 7, n^o 4,‎ 1995, p. 481–487 (DOI 10.1016/0899-3289(95)90017-9).
(en) Bair, MJ, Robinson, RL, Katon, W et Kroenke, K., Depression and Pain Comorbidity: A Literature Review, vol. 163, 2003 (PMID 14609780, DOI 10.1001/archinte.163.20.2433, lire en ligne), chap. 20, p. 2433–2445.
(en) Posternak MA, Miller I, « Untreated short-term course of major depression: A meta-analysis of outcomes from studies using wait-list control groups », Journal of Affective Disorders, vol. 66, n^os 2–3,‎ 2001, p. 139–146 (PMID 11578666, DOI 10.1016/S0165-0327(00)00304-9).
(en) Posternak MA, Solomon DA, Leon AC, « The naturalistic course of unipolar major depression in the absence of somatic therapy », Journal of Nervous and Mental Disease, vol. 194, n^o 5,‎ 2006, p. 324–329 (PMID 16699380, DOI 10.1097/01.nmd.0000217820.33841.53).
(en) Fava GA, Park SK, Sonino N, « Treatment of recurrent depression », Expert Review of Neurotherapeutics, vol. 6, n^o 11,‎ 2006, p. 1735–1740 (PMID 17144786, DOI 10.1586/14737175.6.11.1735).
(fr) Limosin F, Mekaoui L, Hautecouverture S, « Stratégies thérapeutiques prophylactiques dans la dépression unipolaire [Prophylactic treatment for recurrent major depression] », La Presse Médicale, vol. 36, n^o 11-C2,‎ 2007, p. 1627–1633 (PMID 17555914, DOI 10.1016/j.lpm.2007.03.032).
(en) Eaton WW, Shao H, Nestadt G, « Population-based study of first onset and chronicity in major depressive disorder », Archives of General Psychiatry, vol. 65, n^o 5,‎ 2008, p. 513–520 (PMID 18458203, PMCID 2761826, DOI 10.1001/archpsyc.65.5.513).
(en) Holma KM, Holma IA, Melartin TK, « Long-term outcome of major depressive disorder in psychiatric patients is variable », Journal of Clinical Psychiatry, vol. 69, n^o 2,‎ 2008, p. 196–205 (PMID 18251627, DOI 10.4088/JCP.v69n0205).
(en) Kanai T, Takeuchi H, Furukawa TA, « Time to recurrence after recovery from major depressive episodes and its predictors », Psychological Medicine, vol. 33, n^o 5,‎ 2003, p. 839–845 (PMID 12877398, DOI 10.1017/S0033291703007827).
(en) Geddes JR, Carney SM, Davies C, « Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review », Lancet, vol. 361, n^o 9358,‎ 2003, p. 653–661 (PMID 12606176, DOI 10.1016/S0140-6736(03)12599-8).
(en) Cassano P, Fava M, « Depression and public health: an overview », J Psychosom Res, vol. 53, n^o 4,‎ 2002, p. 849–857 (PMID 12377293, DOI 10.1016/S0022-3999(02)00304-5).
(en) Blair-West GW, Mellsop GW, « Major depression: Does a gender-based down-rating of suicide risk challenge its diagnostic validity? », Australian and New Zealand Journal of Psychiatry, vol. 35, n^o 3,‎ 2001, p. 322–328 (PMID 11437805, DOI 10.1046/j.1440-1614.2001.00895.x).
(en) Oquendo MA, Bongiovi-Garcia ME, Galfalvy H, « Sex differences in clinical predictors of suicidal acts after major depression: a prospective study », The American journal of psychiatry, vol. 164, n^o 1,‎ 2007, p. 134–141 (PMID 17202555, DOI 10.1176/appi.ajp.164.1.134).
(en) Mathers CD, Loncar D, « Projections of global mortality and burden of disease from 2002 to 2030 », PLoS Med., vol. 3, n^o 11,‎ 2006, e442 (PMID 17132052, PMCID 1664601, DOI 10.1371/journal.pmed.0030442).
(en) Ricardo F Muñoz, « Major depression can be prevented », The American psychologist, vol. 67, n^o 4,‎ 2012, p. 285–295 (DOI 10.1037/a0027666).
(en) van Straten A et Cuijpers P, « Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions », Am J Psychiatry, vol. 165, n^o 10,‎ 2008, p. 1272–1280 (DOI 10.1176/appi.ajp.2008.07091422).
(en) Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM, « Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later », Clinical Psychology Review, vol. 29, n^o 5,‎ 2009, p. 449–458 (PMID 19450912, DOI 10.1016/j.cpr.2009.04.005).
(en) van't Veer-Tazelaar PJ, van Marwijk HW, van Oppen P et al., « Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial », Arch. Gen. Psychiatry, vol. 66, n^o 3,‎ mars 2009, p. 297–304 (PMID 19255379, DOI 10.1001/archgenpsychiatry.2008.555).
(en) P Stallard, K Sayal, R Phillips, JA Taylor, M Spears, R Anderson, R Araya, G Lewis et A Millings, « Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: Pragmatic cluster randomised controlled trial », BMJ (Clinical research ed.), vol. 345,‎ 2012, e6058 (PMID 23043090, PMCID 3465253, DOI 10.1136/bmj.e6058, lire en ligne).
(en) G. N. Clarke, W. Hawkins, M. Murphy et L. Sheeber, « School-Based Primary Prevention of Depressive Symptomatology in Adolescents: Findings from Two Studies », Journal of Adolescent Research, vol. 8, n^o 2,‎ 1993, p. 183 (DOI 10.1177/074355489382004, lire en ligne).
Rita Indirli, Valeria Lanzi, Maura Arosio et Giovanna Mantovani, « The association of hypogonadism with depression and its treatments », Frontiers in Endocrinology, vol. 14,‎ 2023, p. 1198437 (ISSN 1664-2392, PMID 37635965, PMCID PMC10449581, DOI 10.3389/fendo.2023.1198437, lire en ligne, consulté le 4 mars 2024)
Shogo Sato et Paolo Sassone-Corsi, « Linking Depression to Epigenetics: Role of the Circadian Clock », Advances in Experimental Medicine and Biology, vol. 1344,‎ 2021, p. 43–53 (ISSN 0065-2598, PMID 34773225, DOI 10.1007/978-3-030-81147-1_3, lire en ligne, consulté le 4 mars 2024)
(en) Clara Humpston, Francesco Benedetti, Marc Serfaty et Sarah Markham, « Chronotherapy for the rapid treatment of depression: A meta-analysis », Journal of Affective Disorders, vol. 261,‎ janvier 2020, p. 91–102 (DOI 10.1016/j.jad.2019.09.078, lire en ligne, consulté le 4 mars 2024)
(en) Thase, ME, « When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder? », Psychiatric Quarterly, vol. 70, n^o 4,‎ 1999, p. 333–346 (PMID 10587988, DOI 10.1023/A:1022042316895).
(en) Wilson KC, Mottram PG, Vassilas CA, « Psychotherapeutic treatments for older depressed people », Cochrane Database of Systematic Reviews, vol. 23, n^o 1,‎ 2008, p. CD004853 (PMID 18254062, DOI 10.1002/14651858.CD004853.pub2).
(en) Cuijpers P, van Straten A, Smit F, « Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials », International Journal of Geriatric Psychiatry, vol. 21, n^o 12,‎ 2006, p. 1139–1149 (PMID 16955421, DOI 10.1002/gps.1620).
(en) Dobson KS, « A meta-analysis of the efficacy of cognitive therapy for depression », J Consult Clin Psychol, vol. 57, n^o 3,‎ 1989, p. 414–419 (PMID 2738214, DOI 10.1037/0022-006X.57.3.414).
(en) Weersing, VR et Walker, PN, « Review: Cognitive behavioural therapy for adolescents with depression », Evidence-Based Mental Health, vol. 11, n^o 3,‎ 2008, p. 76 (PMID 18669678, DOI 10.1136/ebmh.11.3.76, lire en ligne, consulté le 28 novembre 2008).
(en) Harrington R, Whittaker J, Shoebridge P, Campbell F, « Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder », BMJ, vol. 325, n^o 7358,‎ 1998, p. 229–230 (PMID 9596592, PMCID 28555, DOI 10.1136/bmj.325.7358.229).
(en) Paykel ES, « Cognitive therapy in relapse prevention in depression », The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), vol. 10, n^o 1,‎ 2007, p. 131–136 (PMID 16787553, DOI 10.1017/S1461145706006912).
(en) Coelho HF, Canter PH, Ernst E, « Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research », Journal of Consulting and Clinical Psychology, vol. 75, n^o 6,‎ 2007, p. 1000–1005 (PMID 18085916, DOI 10.1037/0022-006X.75.6.1000).
(en) Doidge N, Simon B, Lancee WJ, « Psychoanalytic patients in the US, Canada, and Australia: II. A DSM-III-R validation study », Journal of the American Psychoanalytic Association, vol. 50, n^o 2,‎ 2002, p. 615–627 (PMID 12206545, DOI 10.1177/00030651020500021101).
(en) de Maat S, Dekker J, Schoevers R, « Short Psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: A mega-analysis based on three Randomized Clinical Trials », Depression and Anxiety, vol. 25, n^o 7,‎ 2007, p. 565 (PMID 17557313, DOI 10.1002/da.20305).
(en) Fournier JC, DeRubeis RJ, Hollon SD et al., « Antidepressant drug effects and depression severity: a patient-level meta-analysis », JAMA, vol. 303, n^o 1,‎ janvier 2010, p. 47–53 (PMID 20051569, DOI 10.1001/jama.2009.1943).
(en) Cuijpers P, van Straten A, van Oppen P, Andersson G, « Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies », Journal of Clinical Psychiatry, vol. 69, n^o 11,‎ 2008, p. 1675–1685 (PMID 18945396, DOI 10.4088/JCP.v69n1102).
(en) Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Andersson G., « Psychotherapy for chronic major depression and dysthymia: a meta-analysis », Clinical Psychology Review, vol. 30, n^o 1,‎ 2010, p. 51–62 (PMID 19766369, DOI 10.1016/j.cpr.2009.09.003).
(en) Whooley MA, Simon GE, « Managing Depression in Medical Outpatients », New England Journal of Medicine, vol. 343, n^o 26,‎ 2000, p. 1942–1950 (PMID 11136266, DOI 10.1056/NEJM200012283432607, lire en ligne).
(en) Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB, « Use of bupropion in combination with serotonin reuptake inhibitors », Biological Psychiatry, vol. 59, n^o 3,‎ 2006, p. 203–210 (PMID 16165100, DOI 10.1016/j.biopsych.2005.06.027).
(en) Niederehe, G. et al., « Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression », New England Journal of Medicine, vol. 354, n^o 12,‎ 2006, p. 1231–1242 (PMID 16554525, DOI 10.1056/NEJMoa052963).
(en) Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ, « Medication augmentation after the failure of SSRIs for depression », New England Journal of Medicine, vol. 354, n^o 12,‎ 2006, p. 1243–1252 (PMID 16554526, DOI 10.1056/NEJMoa052964).
(en) Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC, « Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents », Biological Psychiatry, vol. 62, n^o 11,‎ 2007, p. 1217–1227 (PMID 17588546, DOI 10.1016/j.biopsych.2007.03.027).
(en) Baldwin DS et Mayers AG, « Antidepressants and their effect on sleep », Human Psychopharmacology, vol. 20, n^o 8,‎ 2005, p. 533–559 (PMID 16229049, DOI 10.1002/hup.726).
(en) Soldani F et Tsapakis EM, « Efficacy of antidepressants in juvenile depression: meta-analysis », Br J Psychiatry, vol. 193, n^o 1,‎ 2008, p. 10–17 (DOI 10.1192/bjp.bp.106.031088).
(en) JC Nelson, « A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia », Journal of the American Geriatrics Society, vol. 59, n^o 4,‎ 2011, p. 577–585 (PMID 21453380, DOI 10.1111/j.1532-5415.2011.03355.x).
(en) Gates J et Palmer B, « Causes and Management of Hyponatremia », The Annals of Pharmacotherapy, vol. 37, n^o 11,‎ 2003, p. 1694–1702 (PMID 14565794, DOI 10.1345/aph.1D105).
(en) Barbui C. et Guaiana G., « Amitriptyline for depression », Cochrane Database Syst Review, vol. 18, n^o 3,‎ 2007, p. 11–17 (PMID 17636748, DOI 10.1002/14651858.CD004186.pub2).
(en) Anderson IM, « Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability », Journal of Affective Disorders, vol. 58, n^o 1,‎ 2000, p. 19–36 (PMID 10760555, DOI 10.1016/S0165-0327(99)00092-0).
Bonnet U, « Moclobemide: therapeutic use and clinical studies », CNS Drug Rev, vol. 9, n^o 1,‎ 2003, p. 97–140 (PMID 12595913, DOI 10.1111/j.1527-3458.2003.tb00245.x).
(en) Chanaka Wijeratne, « Treatment-resistant depression: Critique of current approaches », Australian and New Zealand Journal of Psychiatry, vol. 42, n^o 9,‎ 2008, p. 751–762 (PMID 18696279, DOI 10.1080/00048670802277206).
(en) Marcus SC et Olfson M, « Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study », Archives of General Psychiatry, vol. 63, n^o 8,‎ 2006, p. 865–872 (PMID 16894062, DOI 10.1001/archpsyc.63.8.865).
(en) Merry S et Hetrick S, « Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents », Cochrane Database Syst Rev, n^o 3,‎ 2007, p. CD004851 (DOI 10.1002/14651858.CD004851.pub2).
(en) Saperia J et Gunnell D, « Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review », BMJ, vol. 330, n^o 7488,‎ 2005, p. 385 (PMID 15718537, PMCID 549105, DOI 10.1136/bmj.330.7488.385).
(en) Doucette S et Fergusson D, « Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials », BMJ, vol. 330, n^o 7488,‎ 2005, p. 396 (DOI 10.1136/bmj.330.7488.396).
(en) M Stone, « Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration », BMJ (Clinical research ed.), vol. 339,‎ 2009, b2880 (PMID 19671933, DOI 10.1136/bmj.b2880).
(en) Akiskal H et Rihmer Z, « Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries », J Affect Disord, vol. 94, n^os 1–3,‎ 2006, p. 3–13 (DOI 10.1016/j.jad.2006.04.003).
(en) A. Cipriani, « Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis », BMJ, vol. 346, n^o jun27 4,‎ '"`uniq--nowiki-00000522-qinu`"'.^[quand ?], f3646–f3646 (DOI 10.1136/bmj.f3646).
(en) Ellis SP et Sublette ME, « Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression », J Clin Psychiatry, vol. 72, n^o 12,‎ septembre 2011, p. 1577–1584 (DOI 10.4088/JCP.10m06634).
(en) Hannestad J et Bloch MH, « Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis », Mol Psychiatry, vol. 17, n^o 12,‎ septembre 2011, p. 1272–1282 (DOI 10.1038/mp.2011.100).
(en) Janine Joyce et G Peter Herbison, « Reiki for depression and anxiety », Cochrane Database of Systematic Reviews,‎ 3 avril 2015 (DOI 10.1002/14651858.CD006833.pub2, lire en ligne, consulté le 7 mai 2021)
(en) Bonnie Meekums, Vicky Karkou et E Andrea Nelson, « Dance movement therapy for depression », Cochrane Database of Systematic Reviews,‎ 19 février 2015 (DOI 10.1002/14651858.CD009895.pub2, lire en ligne, consulté le 7 mai 2021)
(en) Nicola Black, Emily Stockings, Gabrielle Campbell et Lucy T Tran, « Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis », The Lancet Psychiatry, vol. 6, n^o 12,‎ 2019-12-xx, p. 995–1010 (DOI 10.1016/S2215-0366(19)30401-8, lire en ligne, consulté le 7 mai 2021)
Michael Noetel, Taren Sanders, Daniel Gallardo-Gómez et Paul Taylor, « Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials », BMJ (Clinical research ed.), vol. 384,‎ 14 février 2024, e075847 (ISSN 1756-1833, PMID 38355154, PMCID PMC10870815, DOI 10.1136/bmj-2023-075847, lire en ligne, consulté le 4 mars 2024)
(en) Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge et Lysia Demetriou, « Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms », Scientific Reports, vol. 7, n^o 1,‎ 13 octobre 2017 (ISSN 2045-2322, DOI 10.1038/s41598-017-13282-7, lire en ligne, consulté le 13 octobre 2018)
(en) UK ECT Review Group, « Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis », Lancet, vol. 361, n^o 9360,‎ 2003, p. 799–808 (PMID 12642045, DOI 10.1016/S0140-6736(03)12705-5).
(en) Kellner CH et Bourgon LN, « Relapse of depression after ECT: a review », The journal of ECT, vol. 16, n^o 1,‎ 2000, p. 19–31 (DOI 10.1097/00124509-200003000-00003, lire en ligne).
(en) R. F. Haskett et H. A. Sackeim, « Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial », JAMA: Journal of the American Medical Association, vol. 285, n^o 10,‎ 2001, p. 1299–1307 (DOI 10.1001/jama.285.10.1299, lire en ligne).
(en) Mulsant BH et Tew JD, « Relapse during continuation pharmacotherapy after acute response to ECT: A comparison of usual care versus protocolized treatment », Annals of Clinical Psychiatry, vol. 19, n^o 1,‎ 2007, p. 1–4 (DOI 10.1080/10401230601163360).
(en) Petrides G et Frederikse M, « Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report », The journal of ECT, vol. 22, n^o 1,‎ 2006, p. 13–17 (PMID 16633200, DOI 10.1097/00124509-200603000-00003, lire en ligne).
(en) Caraveo-A. et Andrade L, « Epidemiology of major depressive episodes: Results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys », Int J Methods Psychiatr Res, vol. 12, n^o 1,‎ 2005, p. 3–21 (DOI 10.1002/mpr.138, lire en ligne).
(en) Berglund P et Kessler RC, « Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication », Archives of General Psychiatry, vol. 62, n^o 6,‎ 2005, p. 593–602 (DOI 10.1001/archpsyc.62.6.593).
(en) Laird NM et Murphy JM, « A 40-year perspective on the prevalence of depression: The Stirling County Study », Archives of General Psychiatry, vol. 57, n^o 3,‎ 2000, p. 209–215 (DOI 10.1001/archpsyc.57.3.209).
(en) C Kuehner, « Gender differences in unipolar depression: An update of epidemiological findings and possible explanations », Acta Psychiatrica Scandinavica, vol. 108, n^o 3,‎ 2003, p. 163–174 (DOI 10.1034/j.1600-0447.2003.00204.x).
(en) Rickards H, « Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke », Journal of Neurology Neurosurgery and Psychiatry, vol. 76,‎ 2005, i48–i52 (DOI 10.1136/jnnp.2004.060426, lire en ligne).
(en) Honig A et Strik JJ, « Depression and myocardial infarction: relationship between heart and mind », Progress in neuro-psychopharmacology & biological psychiatry, vol. 25, n^o 4,‎ 2001, p. 879–892 (DOI 10.1016/S0278-5846(01)00150-6).
(en) Jorm AF, « Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span », Psychological Medicine, vol. 30, n^o 1,‎ 2000, p. 11–22 (DOI 10.1017/S0033291799001452).
(en) Berrios GE, « Melancholia and depression during the 19th century: A conceptual history », British Journal of Psychiatry, vol. 153,‎ 1988, p. 298–304 (DOI 10.1192/bjp.153.3.298).
(en) K Davison, « Historical aspects of mood disorders », Psychiatry, vol. 5, n^o 4,‎ 2006, p. 115–118 (DOI 10.1383/psyt.2006.5.4.115).
(en) AJ Lewis, « Melancholia: A historical review », Journal of Mental Science, vol. 80,‎ 1934, p. 1–42 (DOI 10.1192/bjp.80.328.1).
(en) Schildkraut, JJ, « The catecholamine hypothesis of affective disorders: A review of supporting evidence », American Journal of Psychiatry, vol. 122, n^o 5,‎ 1965, p. 509–522 (PMID 5319766, DOI 10.1176/appi.ajp.122.5.509).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.
(en) Tom G. Bolwig et Edward Shorter, « Melancholia: Beyond DSM, beyond neurotransmitters. Proceedings of a conference, May 2006, Copenhagen, Denmark », Acta Psychiatrica Scandinavica Suppl, vol. 115, n^o 433,‎ 2007, p. 4–183 (DOI 10.1111/j.1600-0447.2007.00956.x).
(en) Bolwig TG et Fink M, « Melancholia: Restoration in psychiatric classification recommended », Acta Psychiatrica Scandinavica, vol. 115, n^o 2,‎ 2007, p. 89–92 (PMID 17244171, DOI 10.1111/j.1600-0447.2006.00943.x).
(en) Karasz A, « Cultural differences in conceptual models of depression », Social Science in Medicine, vol. 60, n^o 7,‎ 2005, p. 1625–1635 (PMID 15652693, DOI 10.1016/j.socscimed.2004.08.011).
(en) F Tilbury, « There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress », Health Sociology Review, vol. 13, n^o 1,‎ 2004, p. 54–64 (DOI 10.5555/hesr.2004.13.1.54, lire en ligne).
(en) F Tilbury, « There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress », Health Sociology Review, vol. 13, n^o 1,‎ 2004, p. 54–64. (PMID 11384889, DOI 10.5555/hesr.2004.13.1.54, lire en ligne)
(en) Gordon Parker, « Is depression overdiagnosed? Yes », BMJ, vol. 335, n^o 7615,‎ 2007, p. 328 (DOI 10.1136/bmj.39268.475799.AD, lire en ligne).
(en) Bentall R, Pilgrim D, « The medicalisation of misery: A critical realist analysis of the concept of depression », Journal of Mental Health, vol. 8, n^o 3,‎ 1999, p. 261–274. (DOI 10.1080/09638239917580, lire en ligne)
(en) Palmer BW, Jeste ND, « Tennessee Williams », American Journal of Geriatric Psychiatry, vol. 12, n^o 4,‎ 2004, p. 370–375 (PMID 15249274, DOI 10.1176/appi.ajgp.12.4.370).
(en) Hart D, Paykel ES, « Changes in public attitudes to depression during the Defeat Depression Campaign », British Journal of Psychiatry, vol. 173,‎ 1998, p. 519–522 (PMID 9926082, DOI 10.1192/bjp.173.6.519).

efpa.eu

congres.efpa.eu

(en) Cuijpers, P., « Prevention and early treatment of mental ill-health » [PDF], 20 septembre 2012. VU university medical center.

elsevier.com

linkinghub.elsevier.com

(en) Clara Humpston, Francesco Benedetti, Marc Serfaty et Sarah Markham, « Chronotherapy for the rapid treatment of depression: A meta-analysis », Journal of Affective Disorders, vol. 261,‎ janvier 2020, p. 91–102 (DOI 10.1016/j.jad.2019.09.078, lire en ligne, consulté le 4 mars 2024)
(en) Nicola Black, Emily Stockings, Gabrielle Campbell et Lucy T Tran, « Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis », The Lancet Psychiatry, vol. 6, n^o 12,‎ 2019-12-xx, p. 995–1010 (DOI 10.1016/S2215-0366(19)30401-8, lire en ligne, consulté le 7 mai 2021)

emedicine.com

(en) Ruta M Nonacs, « Postpartum depression », eMedicine, 2007 (consulté le 30 octobre 2008).

emory.edu

des.emory.edu

(en) Bandura A, Encyclopedia of mental health, San Diego, Academic Press, 1998 (ISBN 0-12-226676-5, lire en ligne), « Self-Efficacy ».

europepmc.org

(en) Massie MJ et Holland JC, « Depression and the cancer patient. », The Journal of clinical psychiatry, vol. 51 Suppl,‎ juillet 1990 (ISSN 0160-6689, lire en ligne, consulté le 30 juin 2017)

fda.gov

(en) Jones ML Stone MB, « Clinical review: relationship between antidepressant drugs and suicidality in adults » [PDF], Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC), 2006 (consulté le 22 septembre 2007).
(en) Holland C Levenson M, « Statistical Evaluation of Suicidality in Adults Treated with Antidepressants » [PDF], Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC), 2006 (consulté le 22 septembre 2007).
(en) Hammad TA, « Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidality » [PDF], FDA, 2004 (consulté le 29 mai 2008).
(en) « FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications », FDA, 2007 (consulté le 29 mai 2008).

findarticles.com

(en) Blair RG, « Helping older adolescents search for meaning in depression », sur Journal of Mental Health Counseling, 2004 (consulté le 6 novembre 2008).

forbes.com

(en) Robert Langreth, « Study Undermines Case for Antidepressants », Forbes,‎ 2010 (lire en ligne).

frx.com

(en) « Lexapro Prescribing Information for the U.S. » [PDF], Forest Laboratories, 2009 (consulté le 9 avril 2009).

google.co.uk

books.google.co.uk

(en) Janicak, Philip G., Marder, Stephen R. et Pavuluri, Mani N., Principles and practice of psychopharmacotherapy, Philadélphie, Wolters Kluwer Health/Lippincott Williams Wilkins, 2011, 700 p. (ISBN 978-1-60547-565-3, lire en ligne), p. 507–508.
(en) Bankole A. Johnson, Addiction medicine : science and practic, New York, Springer, 2011 (ISBN 978-1-4419-0337-2, lire en ligne), p. 301–303.

googleusercontent.com

webcache.googleusercontent.com

(en) Slavich GM, « Deconstructing depression: A diathesis-stress perspective »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, APS Observer (consulté le 11 novembre 2008).
(en) Kay Jamison, « Brain Damage in Depression and Bipolar Disorder »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, McMan's Depression and Bipolar Web, 21 janvier 2004.
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
« Thérapie interpersonnelle dans le traitement de la dépression majeure »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)} [PDF], sur Regroupement.net (consulté le 8 avril 2011).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.

guideline.gov

(en) American Psychiatric Association, « Practice guideline for the treatment of patients with major depressive disorder », American Journal of Psychiatry, vol. 157, n^o Supp 4,‎ 2000, p. 1–45 (PMID 10767867, lire en ligne).

harvard.edu

ui.adsabs.harvard.edu

(en) Caspi A, Sugden K, Moffitt TE, « Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene », Science, vol. 301, n^o 5631,‎ 2003, p. 386–389 (PMID 12869766, DOI 10.1126/science.1083968, Bibcode 2003Sci...301..386C).

has-sante.fr

Haute Autorité de Santé, « Épisode dépressif caractérisé de l’adulte : prise en charge en soins de premier recours : Méthode Recommandations pour la pratique clinique », Texte des recommandations,‎ octobre 2017 (lire en ligne)

health.am

(en) « Major Depressive Disorder », American Medical Network, Inc. (consulté le 15 janvier 2011).

ingenta.com

openurl.ingenta.com

(en) Morris BH, Bylsma LM, Rottenberg J, « Does emotion predict the course of major depressive disorder? A review of prospective studies », Br J Clin Psychol, vol. 48, n^o Pt 3,‎ septembre 2009, p. 255–273 (PMID 19187578, DOI 10.1348/014466508X396549, lire en ligne).

ingentaconnect.com

(en) McCullough, Michael; Larson, David, « Religion and depression: a review of the literature », Twin Research, Australian Academic Press, vol. 2, n^o 2,‎ 1^er juin 1999, p. 126–136 (PMID 10480747, DOI 10.1375/136905299320565997, lire en ligne).
(en) Bentall R, Pilgrim D, « The medicalisation of misery: A critical realist analysis of the concept of depression », Journal of Mental Health, vol. 8, n^o 3,‎ 1999, p. 261–274. (DOI 10.1080/09638239917580, lire en ligne)

inra.fr

Étude INRA-INSERM sur les carences en oméga-3

issn.org

portal.issn.org

Yujie Zhao, Liu Yang, Barbara J. Sahakian et Christelle Langley, « The brain structure, immunometabolic and genetic mechanisms underlying the association between lifestyle and depression », Nature Mental Health, vol. 1, n^o 10,‎ 11 septembre 2023, p. 736–750 (ISSN 2731-6076, DOI 10.1038/s44220-023-00120-1, lire en ligne, consulté le 9 octobre 2023)
(en) Massie MJ et Holland JC, « Depression and the cancer patient. », The Journal of clinical psychiatry, vol. 51 Suppl,‎ juillet 1990 (ISSN 0160-6689, lire en ligne, consulté le 30 juin 2017)
Rita Indirli, Valeria Lanzi, Maura Arosio et Giovanna Mantovani, « The association of hypogonadism with depression and its treatments », Frontiers in Endocrinology, vol. 14,‎ 2023, p. 1198437 (ISSN 1664-2392, PMID 37635965, PMCID PMC10449581, DOI 10.3389/fendo.2023.1198437, lire en ligne, consulté le 4 mars 2024)
Shogo Sato et Paolo Sassone-Corsi, « Linking Depression to Epigenetics: Role of the Circadian Clock », Advances in Experimental Medicine and Biology, vol. 1344,‎ 2021, p. 43–53 (ISSN 0065-2598, PMID 34773225, DOI 10.1007/978-3-030-81147-1_3, lire en ligne, consulté le 4 mars 2024)
Michael Noetel, Taren Sanders, Daniel Gallardo-Gómez et Paul Taylor, « Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials », BMJ (Clinical research ed.), vol. 384,‎ 14 février 2024, e075847 (ISSN 1756-1833, PMID 38355154, PMCID PMC10870815, DOI 10.1136/bmj-2023-075847, lire en ligne, consulté le 4 mars 2024)
(en) Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge et Lysia Demetriou, « Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms », Scientific Reports, vol. 7, n^o 1,‎ 13 octobre 2017 (ISSN 2045-2322, DOI 10.1038/s41598-017-13282-7, lire en ligne, consulté le 13 octobre 2018)

jamanetwork.com

Okereke OI, Reynolds III CF, Mischoulon D et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in Mood Scores, JAMA, 2020;324:471-480

jhu.edu

muse.jhu.edu

(en) J Radden, « Is this dame melancholy?: Equating today's depression and past melancholia », Philosophy, Psychiatry, & Psychology, vol. 10, n^o 1,‎ 2003, p. 37–52 (DOI 10.1353/ppp.2003.0081, lire en ligne).

lefigaro.fr

« Comment une alimentation saine permet de limiter le risque de dépression », sur LEFIGARO, 28 août 2022 (consulté le 30 août 2022)

lepoint.fr

Sophie Bartczak, « Dépression : le sucre et le pain blanc accusés », Le Point,‎ 7 août 2015 (lire en ligne, consulté le 16 juillet 2017)

librapharm.com

(en) Dein, S, « Religion, spirituality and depression: implications for research and treatment », Primary Care and Community Psychiatry, vol. 11, n^o 2,‎ 2006, p. 67–72 (DOI 10.1185/135525706X121110, lire en ligne [PDF], consulté le 21 novembre 2008).

mayoclinic.org

Depression and anxiety: Exercise eases symptoms

mcmanweb.com

(en) Kay Jamison, « Brain Damage in Depression and Bipolar Disorder »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, McMan's Depression and Bipolar Web, 21 janvier 2004.

mdguidelines.com

(en) « Prognosis » (consulté le 16 juillet 2010).

medicalxpress.com

(en) University College London, « No evidence that depression is caused by low serotonin levels, finds comprehensive review », sur medicalxpress.com (consulté le 20 juillet 2022)

mhlw.go.jp

www1.mhlw.go.jp

(ja) Medics and Foods Department, « Pharmaceuticals and Medical Devices Safety Information » [PDF], 261, sur Ministry of Health, Labour and Welfare (Japan).

mhra.gov.uk

(en) Prof Gordon Duff, « The Medicines and Healthcare products Regulatory Agency (MHRA) », 31 mai 2006.

nami.org

(en) Warman DM, Beck AT, « About treatment and supports: Cognitive behavioral therapy », National Alliance on Mental Illness (NAMI) website, 2003 (consulté le 17 octobre 2008).

naturalhealthadvisory.com

Foods That Fight Depression and Anxiety

nature.com

(en) Grégoire Chevalier et al., « Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system », Cell Reports,‎ 11 décembre 2020 (DOI 10.1038/s41467-020-19931-2, lire en ligne, consulté le 13 septembre 2021).
(en) Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge et Lysia Demetriou, « Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms », Scientific Reports, vol. 7, n^o 1,‎ 13 octobre 2017 (ISSN 2045-2322, DOI 10.1038/s41598-017-13282-7, lire en ligne, consulté le 13 octobre 2018)

nejm.org

content.nejm.org

(en) Whooley MA, Simon GE, « Managing Depression in Medical Outpatients », New England Journal of Medicine, vol. 343, n^o 26,‎ 2000, p. 1942–1950 (PMID 11136266, DOI 10.1056/NEJM200012283432607, lire en ligne).

newsweek.com

(en) « FDA approves magic mushrooms depression drug trial », Newsweek,‎ 23 août 2018 (lire en ligne, consulté le 13 octobre 2018)

nice.org.uk

(en) « Treatements and managements of depression of adults… » [PDF], octobre 2009 (consulté le 11 mai 2012).
(en) Depression in children and young people : Identification and management in primary, community and secondary care, NHS National Institute for Health and Clinical Excellence, 2005 (lire en ligne).

nih.gov

ncbi.nlm.nih.gov

(en) Caspi A, Sugden K, Moffitt TE, « Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene », Science, vol. 301, n^o 5631,‎ 2003, p. 386–389 (PMID 12869766, DOI 10.1126/science.1083968, Bibcode 2003Sci...301..386C).
(en) Schmahmann JD. « Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome » J Neuropsychiatry Clin Neurosci, 2004 Summer;16(3):367-78. PMID 15377747.
(en) Konarski JZ. et al. « Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? » J Psychiatry Neurosci. 2005 May;30(3):178-86. PMID 15944742.
(en) Schmahmann JD. et al. « The neuropsychiatry of the cerebellum - insights from the clinic » Cerebellum, 2007;6(3):254-67. PMID 17786822.
(en) L McHenry, « Ethical issues in psychopharmacology », J Med Ethics, n^o 32(7): 405–410.,‎ juillet 2006 (lire en ligne).
(en) Jeffrey R Lacasse, Jonathan Leo, « Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature », PLoS Med, vol. 2, n^o 12,‎ 2005, e392. (lire en ligne) ; Tableau 1 : auteurs qui ne soutiennent pas l'hypothèse ; Tableau 2 : publicité des groupes pharmaceutiques
(en) Hirschfeld RM, « History and evolution of the monoamine hypothesis of depression », Journal of Clinical Psychiatry, vol. 61 Suppl 6,‎ 2000, p. 4–6. (lire en ligne).
(en) Sugden K et Caspi A, « Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene », Science, vol. 301, n^o 5631,‎ juillet 2003, p. 386–389 (PMID 12869766, DOI 10.1126/science.1083968).
(en) Durrant C et Munafò MR, « Gene X environment interactions at the serotonin transporter locus », Biol. Psychiatry, vol. 65, n^o 3,‎ février 2009, p. 211–219. (PMID 18691701, DOI 10.1016/j.biopsych.2008.06.009).
(en) McGuffin P et Uher R, « The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update », Mol. Psychiatry, vol. 15, n^o 1,‎ janvier 2010, p. 18–22 (PMID 20029411, DOI 10.1038/mp.2009.123).
(en) Jeffrey R. Lacasse, and Jonathan Leo, « Ghostwriting at Elite Academic Medical Centers in the United States », PLoS Med., n^o 7(2): e1000230,‎ février 2010, Medical ghostwriting, the practice of pharmaceutical companies secretly authoring journal articles published under the byline of academic researchers, is a troubling phenomenon because it is dangerous to public health. Ghostwriting was once the “dirty little secret” of the medical literature, but this no longer is the case. Pharmaceutical companies have used ghostwriting to market sertraline, olanzapine, gabapentin estrogen replacement therapy, rofecoxib, paroxetine, methylphenidate, milnaciprin, venlafaxine, and dexfenfluramine. Ghostwriting is now known to be a major industry. (lire en ligne)
(en) Le Masurier M Herrmann LL, « White matter hyperintensities in late life depression: a systematic review », Journal of Neurology, Neurosurgery, and Psychiatry, vol. 79, n^o 6,‎ 2008, p. 619–624 (PMID 17717021, DOI 10.1136/jnnp.2007.124651).
(en) Gado MH Sheline YI, « Untreated depression and hippocampal volume loss », American Journal of Psychiatry, vol. 160, n^o 8,‎ 2003, p. 1516–1518 (PMID 12900317, DOI 10.1176/appi.ajp.160.8.1516).
(en) Heninger GR Duman RS, « A molecular and cellular theory of depression », Archives of General Psychiatry, vol. 54, n^o 7,‎ 1997, p. 597–606 (PMID 9236543).
(en) Savitz J Drevets WC, « The subgenual anterior cingulate cortex in mood disorders », CNS Spectrums, vol. 13, n^o 8,‎ 2008, p. 663–681 (PMID 18704022, PMCID 2729429).
(en) Duman R Sen S, « Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications », Biological Psychiatry, vol. 64, n^o 6,‎ 2008, p. 527–532 (PMID 18571629, PMCID 2597158, DOI 10.1016/j.biopsych.2008.05.005).
(en) O'Connor JC et Dantzer R, « From inflammation to sickness and depression: when the immune system subjugates the brain », Nat Rev Neurosci, vol. 9, n^o 1,‎ 2008, p. 46–56 (DOI 10.1038/nrn2297, lire en ligne).
Müller N, Myint AM, Schwarz MJ, « Inflammatory biomarkers and depression », Neurotox Res, vol. 19, n^o 2,‎ février 2011, p. 308–318 (PMID 20658274, DOI 10.1007/s12640-010-9210-2).
(en) Norbury R Cutter WJ, « Oestrogen, brain function, and neuropsychiatric disorders », Journal of Neurology, Neurosurgery and Psychiatry, vol. 74, n^o 7,‎ 2003, p. 837–840 (PMID 12810759, PMCID 1738534, DOI 10.1136/jnnp.74.7.837).
(en) S.L Douma, « Estrogen-related Mood Disorders Reproductive Life Cycle Factors », Advances in Nursing Science, vol. 28, n^o 4,‎ 2005, p. 364–375 (PMID 16292022).
(en) GC Lasiuk et Hegadoren, « The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women », Biological Research for Nursing, vol. 9, n^o 2,‎ 2007, p. 147–160 (PMID 17909167, DOI 10.1177/1099800407305600).
(en) Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M, « Testosterone and depression: systematic review and meta-analysis », J Psychiatr Pract, vol. 15, n^o 4,‎ 2009, p. 289-305. (PMID 19625884, DOI 10.1097/01.pra.0000358315.88931.fc, lire en ligne [html]) modifier
Cottencin O, « [Severe depression and addictions] », Encéphale, vol. 35 Suppl 7,‎ décembre 2009, S264–8 (PMID 20141784, DOI 10.1016/S0013-7006(09)73483-9).
(en) Falk DE, Yi HY, Hilton ME, « Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders », Drug Alcohol Depend, vol. 94, n^os 1–3,‎ 2008, p. 234–245 (PMID 18215474, PMCID 2386955, DOI 10.1016/j.drugalcdep.2007.11.022).
(en) Boden JM, Fergusson DM, « Alcohol and depression », Addiction, vol. 106, n^o 5,‎ mai 2011, p. 906–914 (PMID 21382111, DOI 10.1111/j.1360-0443.2010.03351.x).
(en) Kelley KW, Dantzer R, « Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders », Brain Behav. Immun., vol. 25 Suppl 1,‎ juin 2011, S13–20 (PMID 21193024, DOI 10.1016/j.bbi.2010.12.013).
(en) Riss, J., Cloyd, J., Gates, J. et Collins, S., « Benzodiazepines in epilepsy: pharmacology and pharmacokinetics », Acta Neurol Scand, vol. 118, n^o 2,‎ 2008, p. 69–86 (PMID 18384456, DOI 10.1111/j.1600-0404.2008.01004.x).
(en) Jeronimus B.F., Kotov, R., Riese, H. et Ormel, J., « Neuroticism's prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: a meta-analysis on 59 longitudinal/prospective studies with 443 313 participants », Psychological Medicine,‎ 2016 (PMID 27523506, DOI 10.1017/S0033291716001653, lire en ligne)
(en) Morris BH, Bylsma LM, Rottenberg J, « Does emotion predict the course of major depressive disorder? A review of prospective studies », Br J Clin Psychol, vol. 48, n^o Pt 3,‎ septembre 2009, p. 255–273 (PMID 19187578, DOI 10.1348/014466508X396549, lire en ligne).
(en) McCullough, Michael; Larson, David, « Religion and depression: a review of the literature », Twin Research, Australian Academic Press, vol. 2, n^o 2,‎ 1^er juin 1999, p. 126–136 (PMID 10480747, DOI 10.1375/136905299320565997, lire en ligne).
(en) Moreira-Almeida, A., Neto, FL. et Koenig, HG., « Religiousness and mental health: a review », Rev. Bras. Psyquiatr., vol. 28, n^o 3,‎ septembre 2006, p. 242–250 (PMID 16924349, DOI 10.1590/S1516-44462006005000006, lire en ligne).
(en) Pinto A, Francis G, « Cognitive correlates of depressive symptoms in hospitalized adolescents », Adolescence, vol. 28, n^o 111,‎ 1993, p. 661–672 (PMID 8237551).
(en) Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D, « Mourning and melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry », Annals of General Psychiatry, vol. 7,‎ 2008, p. 9 (PMID 18652673, PMCID 2515304, DOI 10.1186/1744-859X-7-9).
(en) Newport DJ Heim C, « The link between childhood trauma and depression: insights from HPA axis studies in humans », Psychoneuroendocrinology, vol. 33, n^o 6,‎ 2008, p. 693–710 (PMID 18602762, DOI 10.1016/j.psyneuen.2008.03.008).
(en) Monroe SM, Slavich GM, Torres LD, Gotlib IH, « Major life events and major chronic difficulties are differentially associated with history of major depressive episodes », Journal of Abnormal Psychology, vol. 116, n^o 1,‎ 2007, p. 116–124 (PMID 17324022, DOI 10.1037/0021-843X.116.1.116).
(en) Joaquim Radua, Alberto Pertusa et Narcis Cardoner, « Climatic relationships with specific clinical subtypes of depression », Psychiatry Research, vol. 175, n^o 3,‎ 28 février 2010, p. 217–220 (PMID 20045197, DOI 10.1016/j.psychres.2008.10.025).
Depressive symptoms and self-reported fast-food intake in midlife women
Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort
… chez les jeunes filles notamment : Sanchez-Gonzalez MA, May RW, Koutnik AP, Kabbaj M, Fincham FD (2013), (en) Sympathetic vasomotor tone is associated with depressive symptoms in young females: a potential link between depression and cardiovascular disease ; Am J Hypertens. 2013 Dec;26(12):1389-97. doi: 10.1093/ajh/hpt131. Epub 2013 Aug 9 (résumé).
(en) Kaufmann IM, « Rural psychiatric services. A collaborative model », Canadian Family Physician, vol. 39,‎ 1^er septembre 1993, p. 1957–1961 (PMID 8219844).
(en) Maclullich AM et Reid LM, « Subjective memory complaints and cognitive impairment in older people », Dementia and geriatric cognitive disorders, vol. 22, n^os 5–6,‎ 2006, p. 471–485 (PMID 17047326, DOI 10.1159/000096295).
(en) Katz IR, « Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias », The Journal of clinical psychiatry, vol. 59 Suppl 9,‎ 1998, p. 38–44 (PMID 9720486).
(en) Benazzi F et Akiskal HS, « The DSM-⁵ and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: Evidence that they lie on a dimensional spectrum », Journal of Affective Disorders, vol. 92, n^o 1,‎ 2006, p. 45–54 (PMID 16488021, DOI 10.1016/j.jad.2005.12.035).
(en) Bair, MJ, Robinson, RL, Katon, W et Kroenke, K., Depression and Pain Comorbidity: A Literature Review, vol. 163, 2003 (PMID 14609780, DOI 10.1001/archinte.163.20.2433, lire en ligne), chap. 20, p. 2433–2445.
(en) Posternak MA, Miller I, « Untreated short-term course of major depression: A meta-analysis of outcomes from studies using wait-list control groups », Journal of Affective Disorders, vol. 66, n^os 2–3,‎ 2001, p. 139–146 (PMID 11578666, DOI 10.1016/S0165-0327(00)00304-9).
(en) Posternak MA, Solomon DA, Leon AC, « The naturalistic course of unipolar major depression in the absence of somatic therapy », Journal of Nervous and Mental Disease, vol. 194, n^o 5,‎ 2006, p. 324–329 (PMID 16699380, DOI 10.1097/01.nmd.0000217820.33841.53).
(en) Fava GA, Park SK, Sonino N, « Treatment of recurrent depression », Expert Review of Neurotherapeutics, vol. 6, n^o 11,‎ 2006, p. 1735–1740 (PMID 17144786, DOI 10.1586/14737175.6.11.1735).
(fr) Limosin F, Mekaoui L, Hautecouverture S, « Stratégies thérapeutiques prophylactiques dans la dépression unipolaire [Prophylactic treatment for recurrent major depression] », La Presse Médicale, vol. 36, n^o 11-C2,‎ 2007, p. 1627–1633 (PMID 17555914, DOI 10.1016/j.lpm.2007.03.032).
(en) Eaton WW, Shao H, Nestadt G, « Population-based study of first onset and chronicity in major depressive disorder », Archives of General Psychiatry, vol. 65, n^o 5,‎ 2008, p. 513–520 (PMID 18458203, PMCID 2761826, DOI 10.1001/archpsyc.65.5.513).
(en) Holma KM, Holma IA, Melartin TK, « Long-term outcome of major depressive disorder in psychiatric patients is variable », Journal of Clinical Psychiatry, vol. 69, n^o 2,‎ 2008, p. 196–205 (PMID 18251627, DOI 10.4088/JCP.v69n0205).
(en) Kanai T, Takeuchi H, Furukawa TA, « Time to recurrence after recovery from major depressive episodes and its predictors », Psychological Medicine, vol. 33, n^o 5,‎ 2003, p. 839–845 (PMID 12877398, DOI 10.1017/S0033291703007827).
(en) Geddes JR, Carney SM, Davies C, « Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review », Lancet, vol. 361, n^o 9358,‎ 2003, p. 653–661 (PMID 12606176, DOI 10.1016/S0140-6736(03)12599-8).
(en) Cassano P, Fava M, « Depression and public health: an overview », J Psychosom Res, vol. 53, n^o 4,‎ 2002, p. 849–857 (PMID 12377293, DOI 10.1016/S0022-3999(02)00304-5).
(en) Rush AJ, « The varied clinical presentations of major depressive disorder », The Journal of clinical psychiatry, vol. 68, n^o Supplement 8,‎ 2007, p. 4–10 (PMID 17640152).
(en) Blair-West GW, Mellsop GW, « Major depression: Does a gender-based down-rating of suicide risk challenge its diagnostic validity? », Australian and New Zealand Journal of Psychiatry, vol. 35, n^o 3,‎ 2001, p. 322–328 (PMID 11437805, DOI 10.1046/j.1440-1614.2001.00895.x).
(en) Oquendo MA, Bongiovi-Garcia ME, Galfalvy H, « Sex differences in clinical predictors of suicidal acts after major depression: a prospective study », The American journal of psychiatry, vol. 164, n^o 1,‎ 2007, p. 134–141 (PMID 17202555, DOI 10.1176/appi.ajp.164.1.134).
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
(en) Mathers CD, Loncar D, « Projections of global mortality and burden of disease from 2002 to 2030 », PLoS Med., vol. 3, n^o 11,‎ 2006, e442 (PMID 17132052, PMCID 1664601, DOI 10.1371/journal.pmed.0030442).
(en) Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM, « Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later », Clinical Psychology Review, vol. 29, n^o 5,‎ 2009, p. 449–458 (PMID 19450912, DOI 10.1016/j.cpr.2009.04.005).
(en) van't Veer-Tazelaar PJ, van Marwijk HW, van Oppen P et al., « Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial », Arch. Gen. Psychiatry, vol. 66, n^o 3,‎ mars 2009, p. 297–304 (PMID 19255379, DOI 10.1001/archgenpsychiatry.2008.555).
(en) P Stallard, K Sayal, R Phillips, JA Taylor, M Spears, R Anderson, R Araya, G Lewis et A Millings, « Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: Pragmatic cluster randomised controlled trial », BMJ (Clinical research ed.), vol. 345,‎ 2012, e6058 (PMID 23043090, PMCID 3465253, DOI 10.1136/bmj.e6058, lire en ligne).
Rita Indirli, Valeria Lanzi, Maura Arosio et Giovanna Mantovani, « The association of hypogonadism with depression and its treatments », Frontiers in Endocrinology, vol. 14,‎ 2023, p. 1198437 (ISSN 1664-2392, PMID 37635965, PMCID PMC10449581, DOI 10.3389/fendo.2023.1198437, lire en ligne, consulté le 4 mars 2024)
Shogo Sato et Paolo Sassone-Corsi, « Linking Depression to Epigenetics: Role of the Circadian Clock », Advances in Experimental Medicine and Biology, vol. 1344,‎ 2021, p. 43–53 (ISSN 0065-2598, PMID 34773225, DOI 10.1007/978-3-030-81147-1_3, lire en ligne, consulté le 4 mars 2024)
(en) Thase, ME, « When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder? », Psychiatric Quarterly, vol. 70, n^o 4,‎ 1999, p. 333–346 (PMID 10587988, DOI 10.1023/A:1022042316895).
(en) Wilson KC, Mottram PG, Vassilas CA, « Psychotherapeutic treatments for older depressed people », Cochrane Database of Systematic Reviews, vol. 23, n^o 1,‎ 2008, p. CD004853 (PMID 18254062, DOI 10.1002/14651858.CD004853.pub2).
(en) Cuijpers P, van Straten A, Smit F, « Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials », International Journal of Geriatric Psychiatry, vol. 21, n^o 12,‎ 2006, p. 1139–1149 (PMID 16955421, DOI 10.1002/gps.1620).
(en) Dobson KS, « A meta-analysis of the efficacy of cognitive therapy for depression », J Consult Clin Psychol, vol. 57, n^o 3,‎ 1989, p. 414–419 (PMID 2738214, DOI 10.1037/0022-006X.57.3.414).
(en) Weersing, VR et Walker, PN, « Review: Cognitive behavioural therapy for adolescents with depression », Evidence-Based Mental Health, vol. 11, n^o 3,‎ 2008, p. 76 (PMID 18669678, DOI 10.1136/ebmh.11.3.76, lire en ligne, consulté le 28 novembre 2008).
(en) Harrington R, Whittaker J, Shoebridge P, Campbell F, « Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder », BMJ, vol. 325, n^o 7358,‎ 1998, p. 229–230 (PMID 9596592, PMCID 28555, DOI 10.1136/bmj.325.7358.229).
(en) Almeida, AM et Lotufo Neto, F., « Cognitive-behavioral therapy in prevention of depression relapses and recurrences: a review », Revista brasileira de psiquiatria (Sao Paulo, Brésil : 1999), vol. 25, n^o 4,‎ 2003, p. 239–244 (PMID 15328551).
(en) Paykel ES, « Cognitive therapy in relapse prevention in depression », The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), vol. 10, n^o 1,‎ 2007, p. 131–136 (PMID 16787553, DOI 10.1017/S1461145706006912).
(en) Coelho HF, Canter PH, Ernst E, « Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research », Journal of Consulting and Clinical Psychology, vol. 75, n^o 6,‎ 2007, p. 1000–1005 (PMID 18085916, DOI 10.1037/0022-006X.75.6.1000).
(en) Doidge N, Simon B, Lancee WJ, « Psychoanalytic patients in the US, Canada, and Australia: II. A DSM-III-R validation study », Journal of the American Psychoanalytic Association, vol. 50, n^o 2,‎ 2002, p. 615–627 (PMID 12206545, DOI 10.1177/00030651020500021101).
(en) de Maat S, Dekker J, Schoevers R, « Short Psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: A mega-analysis based on three Randomized Clinical Trials », Depression and Anxiety, vol. 25, n^o 7,‎ 2007, p. 565 (PMID 17557313, DOI 10.1002/da.20305).
(en) Fournier JC, DeRubeis RJ, Hollon SD et al., « Antidepressant drug effects and depression severity: a patient-level meta-analysis », JAMA, vol. 303, n^o 1,‎ janvier 2010, p. 47–53 (PMID 20051569, DOI 10.1001/jama.2009.1943).
(en) Cuijpers P, van Straten A, van Oppen P, Andersson G, « Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies », Journal of Clinical Psychiatry, vol. 69, n^o 11,‎ 2008, p. 1675–1685 (PMID 18945396, DOI 10.4088/JCP.v69n1102).
(en) Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon SD, Andersson G., « Psychotherapy for chronic major depression and dysthymia: a meta-analysis », Clinical Psychology Review, vol. 30, n^o 1,‎ 2010, p. 51–62 (PMID 19766369, DOI 10.1016/j.cpr.2009.09.003).
(en) Whooley MA, Simon GE, « Managing Depression in Medical Outpatients », New England Journal of Medicine, vol. 343, n^o 26,‎ 2000, p. 1942–1950 (PMID 11136266, DOI 10.1056/NEJM200012283432607, lire en ligne).
(en) Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB, « Use of bupropion in combination with serotonin reuptake inhibitors », Biological Psychiatry, vol. 59, n^o 3,‎ 2006, p. 203–210 (PMID 16165100, DOI 10.1016/j.biopsych.2005.06.027).
(en) Niederehe, G. et al., « Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression », New England Journal of Medicine, vol. 354, n^o 12,‎ 2006, p. 1231–1242 (PMID 16554525, DOI 10.1056/NEJMoa052963).
(en) Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ, « Medication augmentation after the failure of SSRIs for depression », New England Journal of Medicine, vol. 354, n^o 12,‎ 2006, p. 1243–1252 (PMID 16554526, DOI 10.1056/NEJMoa052964).
(en) Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC, « Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents », Biological Psychiatry, vol. 62, n^o 11,‎ 2007, p. 1217–1227 (PMID 17588546, DOI 10.1016/j.biopsych.2007.03.027).
(en) Baldwin DS et Mayers AG, « Antidepressants and their effect on sleep », Human Psychopharmacology, vol. 20, n^o 8,‎ 2005, p. 533–559 (PMID 16229049, DOI 10.1002/hup.726).
(en) JC Nelson, « A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia », Journal of the American Geriatrics Society, vol. 59, n^o 4,‎ 2011, p. 577–585 (PMID 21453380, DOI 10.1111/j.1532-5415.2011.03355.x).
(en) Gates J et Palmer B, « Causes and Management of Hyponatremia », The Annals of Pharmacotherapy, vol. 37, n^o 11,‎ 2003, p. 1694–1702 (PMID 14565794, DOI 10.1345/aph.1D105).
(en) Barbui C. et Guaiana G., « Amitriptyline for depression », Cochrane Database Syst Review, vol. 18, n^o 3,‎ 2007, p. 11–17 (PMID 17636748, DOI 10.1002/14651858.CD004186.pub2).
(en) Anderson IM, « Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability », Journal of Affective Disorders, vol. 58, n^o 1,‎ 2000, p. 19–36 (PMID 10760555, DOI 10.1016/S0165-0327(99)00092-0).
Bonnet U, « Moclobemide: therapeutic use and clinical studies », CNS Drug Rev, vol. 9, n^o 1,‎ 2003, p. 97–140 (PMID 12595913, DOI 10.1111/j.1527-3458.2003.tb00245.x).
(en) Chanaka Wijeratne, « Treatment-resistant depression: Critique of current approaches », Australian and New Zealand Journal of Psychiatry, vol. 42, n^o 9,‎ 2008, p. 751–762 (PMID 18696279, DOI 10.1080/00048670802277206).
(en) Marcus SC et Olfson M, « Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study », Archives of General Psychiatry, vol. 63, n^o 8,‎ 2006, p. 865–872 (PMID 16894062, DOI 10.1001/archpsyc.63.8.865).
(en) Saperia J et Gunnell D, « Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review », BMJ, vol. 330, n^o 7488,‎ 2005, p. 385 (PMID 15718537, PMCID 549105, DOI 10.1136/bmj.330.7488.385).
(en) M Stone, « Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration », BMJ (Clinical research ed.), vol. 339,‎ 2009, b2880 (PMID 19671933, DOI 10.1136/bmj.b2880).
(en) I Sakinofsky, « Treating suicidality in depressive illness. Part I: current controversies », Canadian Journal of Psychiatry, vol. 52, n^o 6 Suppl 1,‎ 2007, p. 71S–84S (PMID 17824354).
(en) RJ Baldessarini, « Lithium treatment and suicide risk in major affective disorders: update and new findings », The Journal of clinical psychiatry, vol. 64 Suppl 5,‎ 2003, p. 44–52 (PMID 12720484).
(en) Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation
Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: results from a large community-based prospective study
Dietary recommendations for the prevention of depression
Omega-3 fatty acids in depression: a review of three studies
Fasting in mood disorders: neurobiology and effectiveness. A review of the literature
Regular Moderate or Intense Exercise Prevents Depression-Like Behavior without Change of Hippocampal Tryptophan Content in Chronically Tryptophan-Deficient and Stressed Mice
Michael Noetel, Taren Sanders, Daniel Gallardo-Gómez et Paul Taylor, « Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials », BMJ (Clinical research ed.), vol. 384,‎ 14 février 2024, e075847 (ISSN 1756-1833, PMID 38355154, PMCID PMC10870815, DOI 10.1136/bmj-2023-075847, lire en ligne, consulté le 4 mars 2024)
Benefits of Sunlight: A Bright Spot for Human Health
Impact of Windows and Daylight Exposure on Overall Health and Sleep Quality of Office Workers: A Case-Control Pilot Study
(en) American Psychiatric Association, « Practice guideline for the treatment of patients with major depressive disorder », American Journal of Psychiatry, vol. 157, n^o Supp 4,‎ 2000, p. 1–45 (PMID 10767867, lire en ligne).
(en) UK ECT Review Group, « Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis », Lancet, vol. 361, n^o 9360,‎ 2003, p. 799–808 (PMID 12642045, DOI 10.1016/S0140-6736(03)12705-5).
(en) Petrides G et Frederikse M, « Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report », The journal of ECT, vol. 22, n^o 1,‎ 2006, p. 13–17 (PMID 16633200, DOI 10.1097/00124509-200603000-00003, lire en ligne).
(en) Schildkraut, JJ, « The catecholamine hypothesis of affective disorders: A review of supporting evidence », American Journal of Psychiatry, vol. 122, n^o 5,‎ 1965, p. 509–522 (PMID 5319766, DOI 10.1176/appi.ajp.122.5.509).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.
(en) Bolwig TG et Fink M, « Melancholia: Restoration in psychiatric classification recommended », Acta Psychiatrica Scandinavica, vol. 115, n^o 2,‎ 2007, p. 89–92 (PMID 17244171, DOI 10.1111/j.1600-0447.2006.00943.x).
(en) Karasz A, « Cultural differences in conceptual models of depression », Social Science in Medicine, vol. 60, n^o 7,‎ 2005, p. 1625–1635 (PMID 15652693, DOI 10.1016/j.socscimed.2004.08.011).
(en) F Tilbury, « There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress », Health Sociology Review, vol. 13, n^o 1,‎ 2004, p. 54–64. (PMID 11384889, DOI 10.5555/hesr.2004.13.1.54, lire en ligne)
(en) Palmer BW, Jeste ND, « Tennessee Williams », American Journal of Geriatric Psychiatry, vol. 12, n^o 4,‎ 2004, p. 370–375 (PMID 15249274, DOI 10.1176/appi.ajgp.12.4.370).
(en) Tylee A, Paykel ES, « The Defeat Depression Campaign: psychiatry in the public arena », American Journal of Psychiatry, vol. 154, n^o 6 Suppl,‎ 1997, p. 59–65 (PMID 9167546).
(en) Hart D, Paykel ES, « Changes in public attitudes to depression during the Defeat Depression Campaign », British Journal of Psychiatry, vol. 173,‎ 1998, p. 519–522 (PMID 9926082, DOI 10.1192/bjp.173.6.519).

pubmed.ncbi.nlm.nih.gov

Rita Indirli, Valeria Lanzi, Maura Arosio et Giovanna Mantovani, « The association of hypogonadism with depression and its treatments », Frontiers in Endocrinology, vol. 14,‎ 2023, p. 1198437 (ISSN 1664-2392, PMID 37635965, PMCID PMC10449581, DOI 10.3389/fendo.2023.1198437, lire en ligne, consulté le 4 mars 2024)
Shogo Sato et Paolo Sassone-Corsi, « Linking Depression to Epigenetics: Role of the Circadian Clock », Advances in Experimental Medicine and Biology, vol. 1344,‎ 2021, p. 43–53 (ISSN 0065-2598, PMID 34773225, DOI 10.1007/978-3-030-81147-1_3, lire en ligne, consulté le 4 mars 2024)
Michael Noetel, Taren Sanders, Daniel Gallardo-Gómez et Paul Taylor, « Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials », BMJ (Clinical research ed.), vol. 384,‎ 14 février 2024, e075847 (ISSN 1756-1833, PMID 38355154, PMCID PMC10870815, DOI 10.1136/bmj-2023-075847, lire en ligne, consulté le 4 mars 2024)

nlm.nih.gov

(en) « Major Depression » (consulté le 16 juillet 2010).

nihsupp.com

NIH Supplément, « Le magnésium: Vous connaissez ? », sur NIH Supplément, 23 janvier 2024 (consulté le 23 janvier 2024)

nsw.gov.au

health.nsw.gov.au

(en) Faculty of Psychiatry of Old Age, NSW Branch, RANZCP, Consensus Guidelines for Assessment and Management of Depression in the Elderly, North Sydney, New South Wales, NSW Health Department, 2001 (ISBN 0-7347-3341-0, lire en ligne [PDF]), p. 2.

nytimes.com

L Wolpert, « Malignant Sadness: The Anatomy of Depression », The New York Times, 1993 (consulté le 30 octobre 2008).

pbs.org

(en) « Biography of Henry James », Public Broadcasting Service (consulté le 19 août 2008).

pep-web.org

(en) Sterba R, « The 'Mental Crisis' of John Stuart Mill », Psychoanalytic Quarterly, vol. 16, n^o 2,‎ 1947, p. 271–272 (lire en ligne, consulté le 5 novembre 2008).

polytechnique-insights.com

Pierre-Marie Lledo et Gérard Eberl, « Dépression et microbiote : « Une grande révolution médicale arrive » », sur Polytechnique insights, 18 mars 2021 (consulté le 13 septembre 2021).

psu.edu

citeseerx.ist.psu.edu

(en) Haeffel GJ, Getchell M, Koposov RA, Yrigollen CM, DeYoung CG, af Klinteberg B. et al., « Association between polymorphisms in the dopamine transporter gene and depression: Evidence for a gene–environment interaction in a sample of juvenile detainees », Psychological Science, vol. 19, n^o 1,‎ 2008, p. 62-69 (lire en ligne [PDF], consulté le 11 novembre 2008).

pswi.org

(en) Eisner T et Shah N, « An overview of SSRIs for the treatment of depression » [PDF], Journal of the Pharmacy Society of Wisconsin (consulté le 10 novembre 2008).

psychiatrictimes.com

(en) Geppert CMA, « Damage control », sur Psychiatric Times, 2006 (consulté le 8 novembre 2010).
(en) Delgado PL et Schillerstrom J, « Cognitive Difficulties Associated With Depression: What Are the Implications for Treatment? », Psychiatric Times, vol. 26, n^o 3,‎ 2009 (lire en ligne).
(en) Yohannes AM et Baldwin RC, « Medical Comorbidities in Late-Life Depression », Psychiatric Times, vol. 25, n^o 14,‎ 2008 (lire en ligne).
(en) Oepen G et Brunsvold GL, « Comorbid Depression in ADHD: Children and Adolescents », Psychiatric Times, vol. 25, n^o 10,‎ 2008 (lire en ligne).
(en) Schulman J et Shapiro BA, « Depression and Cardiovascular Disease: What Is the Correlation? », Psychiatric Times, vol. 25, n^o 9,‎ 2008 (lire en ligne).
(en) SJ, « Cognitive-Behavioral Therapy for Adolescent Depression: Processes of Cognitive Change », Psychiatric Times, vol. 25, n^o 14,‎ 2008 (lire en ligne).
(en) Barbee JG, « Treatment-Resistant Depression: Advances in Assessment », Psychiatric Times, vol. 25, n^o 10,‎ 2008 (lire en ligne).
(en) DK Simonton, « Are genius and madness related? Contemporary answers to an ancient question », Psychiatric Times, vol. 22, n^o 7,‎ 2005 (> lire en ligne).

psychiatryonline.org

ajp.psychiatryonline.org

(en) Gardner CO et Kendler KS, « Boundaries of major depression: An evaluation of DSM-IV criteria », American Journal of Psychiatry, vol. 155, n^o 2,‎ 1998, p. 172–177 (lire en ligne).

psychologicalscience.org

(en) Slavich GM, « Deconstructing depression: A diathesis-stress perspective »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, APS Observer (consulté le 11 novembre 2008).

psychologytoday.com

(en) « Bedfellows:Insomnia and Depression » (consulté le 2 juillet 2010).

psychomedia.qc.ca

« Dépression: la théorie sous-jacente aux antidépresseurs remise en question », sur psychomedia.qc.ca, 22 juillet 2010 (consulté le 29 avril 2015)

questia.com

(en) Leemon McHenry,, « On the Origin of Great Ideas: Science in the Age of Big Pharma », Hastings Center Report 35, n^o no. 6 : 17-19,‎ 2005, To some extent, academic medicine has long involved ghostwriting. Scientific writers have often written up the results of studies. But while this practice deprives the authors of the credit they rightly deserve, it does not threaten to undermine the scientific integrity of medical research. What is relatively new on the scene is industry-sponsored ghostwriting. (…) In the new, industry-sponsored ghostwriting, pharmaceutical companies fight for market share using "key opinion leaders" paid to sign on to articles authored by marketing departements. (lire en ligne)

rcpsych.org

apt.rcpsych.org

(en) Ma, K, « Attachment theory in adult psychiatry. Part 1: Conceptualisations, measurement and clinical research findings », Advances in Psychiatric Treatment, vol. 12,‎ 2006, p. 440–449 (lire en ligne, consulté le 21 avril 2010).

bjp.rcpsych.org

(en) Jané-Llopis E; Hosman C; Jenkins R; Anderson P., « Predictors of efficacy in depression prevention programmes » [PDF], sur British Journal of Psychiatry, 2003 (consulté le 2 avril 2009).

reference.com

dictionary.reference.com

(en) depress. (n.d.). « Online Etymology Dictionary » (consulté le 30 juin 2008).

regroupement.net

« Thérapie interpersonnelle dans le traitement de la dépression majeure »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)} [PDF], sur Regroupement.net (consulté le 8 avril 2011).

remacle.org

Philippe Remacle (trad. Philippe Remacle, Philippe Renault, François-Dominique Fournier, J. P. Murcia, Thierry Vebr, Caroline Carrat), « Hippocrate. Aphorismes. ΑΦΟΡΙΣΜΟΙ : Section 6 », sur L'antiquité grecque et latine du moyen âge : « 23. Si la crainte ou la tristesse persévère longtemps, cela tient à la mélancolie ».

sagepub.com

pps.sagepub.com

William T. L. Cox, Lyn Y. Abramson, Patricia G. Devine et Steven D. Hollon, « Stereotypes, Prejudice, and Depression: The Integrated Perspective », Perspectives on Psychological Science, vol. 7, n^o 5,‎ 2012, p. 427–449 (DOI 10.1177/1745691612455204, lire en ligne).

jar.sagepub.com

(en) G. N. Clarke, W. Hawkins, M. Murphy et L. Sheeber, « School-Based Primary Prevention of Depressive Symptomatology in Adolescents: Findings from Two Studies », Journal of Adolescent Research, vol. 8, n^o 2,‎ 1993, p. 183 (DOI 10.1177/074355489382004, lire en ligne).

anp.sagepub.com

Coffee and caffeine consumption and depression: A meta-analysis of observational studies

santepubliquefrance.fr

« Dépression et anxiété », sur www.santepubliquefrance.fr (consulté le 9 juin 2022)

sciam.com

(en) Mayberg H, « Brain pathway may underlie depression », Scientific American, vol. 17, n^o 4,‎ 2007, p. 26–31 (lire en ligne).

scielo.br

(en) Moreira-Almeida, A., Neto, FL. et Koenig, HG., « Religiousness and mental health: a review », Rev. Bras. Psyquiatr., vol. 28, n^o 3,‎ septembre 2006, p. 242–250 (PMID 16924349, DOI 10.1590/S1516-44462006005000006, lire en ligne).

sciencedaily.com

(en) « Diet is associated with risk of depression », sur Science Daily.
Treating vitamin D deficiency may improve depression

sciencedirect.com

(en) Eleni Siopi et al., « Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine », Cell Reports, vol. 30, n^o 11,‎ 17 mars 2020, p. 3682-3690 (DOI 10.1016/j.celrep.2020.02.099, lire en ligne, consulté le 13 septembre 2021).

slate.com

(en) Maloney F, « The Depression Wars: Would Honest Abe Have Written the Gettysburg Address on Prozac? », Slate magazine, 2005 (consulté le 3 octobre 2008).

(en) Boeree, CG, « Abraham Maslow: Personality Theories » [PDF], Psychology Department, Shippensburg University, 1998 (consulté le 27 octobre 2008).

springerlink.com

(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.

surgeongeneral.gov

(en) Department of Health and Human Services, « The fundamentals of mental health and mental illness » [PDF], sur Mental Health: A Report of the Surgeon General, 1999 (consulté le 11 novembre 2008).

szasz.com

(en) Steibel W (Producer), « Is depression a disease? », Debatesdebates, 1998 (consulté le 16 novembre 2008).

theatlantic.com

(en) Wolf, Joshua, « Lincoln's Great Depression », sur www.theatlantic.com The Atlantic, octobre 2005 (consulté le 10 octobre 2009).

theconversation.com

(en) Ana Belén Ropero Lara, « Voici comment notre alimentation peut prévenir – ou aggraver – les risques de dépression », sur The Conversation (consulté le 7 septembre 2022)

upenn.edu

garfield.library.upenn.edu

(en) Endicott J Spitzer RL, « The development of diagnostic criteria in psychiatry » [PDF] (consulté le 8 novembre 2008).

web.archive.org

(en) Slavich GM, « Deconstructing depression: A diathesis-stress perspective »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, APS Observer (consulté le 11 novembre 2008).
(en) Depression, National Institute of Mental Health (NIMH) (lire en ligne [PDF]).
(en) « Major Depressive Episode », psychnet-uk.com (version du 15 juillet 2008 sur Internet Archive).
(en) Kay Jamison, « Brain Damage in Depression and Bipolar Disorder »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, McMan's Depression and Bipolar Web, 21 janvier 2004.
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
« Thérapie interpersonnelle dans le traitement de la dépression majeure »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)} [PDF], sur Regroupement.net (consulté le 8 avril 2011).
(en) « Childhood Depression », sur abct.org (version du 26 juillet 2011 sur Internet Archive).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.

webheights.net

(en) E. Pita, « An Intimate Conversation with… Leonard Cohen », 2001 (consulté le 3 octobre 2008).

who.int

(en) « ICD-10: », www.who.int (consulté le 8 novembre 2008).
(en) « Mood (affective) disorders », ICD-10, Chapter V, Mental and behavioural disorders (consulté le 19 octobre 2008).
« ICD-10: », www.who.int (consulté le 6 novembre 2008).
(en) « WHO Disease and injury country estimates », World Health Organization (consulté le 11 novembre 2009).
(en) « Depression », sur www.who.int (consulté le 9 juin 2022)

whp-apsf.ca

(en) Janet C. Currie, Women and Health Protection (Organization), The Marketization of Depression : Prescribing SSRI Antidepressants to Women, Women and Health Protection, 2005, 27 p. (ISBN 0-9738701-0-9, lire en ligne).

wikipedia.org

en.wikipedia.org

(en) Joanna Moncrieff (en), The myth of the chemical cure : a critique of psychiatric drug treatment, Berlin, Springer, 2008 (ISBN 978-0-230-58944-5)

fr.wikipedia.org

(en) Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M, « Testosterone and depression: systematic review and meta-analysis », J Psychiatr Pract, vol. 15, n^o 4,‎ 2009, p. 289-305. (PMID 19625884, DOI 10.1097/01.pra.0000358315.88931.fc, lire en ligne [html]) modifier

wikisource.org

fr.wikisource.org

Aphorismes (Hippocrate)/Section 6 (trad. Ch. V. Daremberg) (Wikisource)

wikiwix.com

archive.wikiwix.com

(en) Slavich GM, « Deconstructing depression: A diathesis-stress perspective »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, APS Observer (consulté le 11 novembre 2008).
Voir également la MRI database sur « www.depressiondatabase.org » (consulté le 15 août 2013).
(en) Kay Jamison, « Brain Damage in Depression and Bipolar Disorder »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, McMan's Depression and Bipolar Web, 21 janvier 2004.
(en) Weich S, Lewis G, « Poverty, unemployment, and common mental disorders: Population based cohort study »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, BMJ, 1998 (PMID 9657786, PMCID 28602), p. 115–119.
« Thérapie interpersonnelle dans le traitement de la dépression majeure »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)} [PDF], sur Regroupement.net (consulté le 8 avril 2011).
(en) Christensen H; Griffiths KM., « The prevention of depression using the Internet » [PDF], sur Medical Journal of Australia, 2002 (consulté le 2 avril 2009).
(en) Maier W et Philipp M, « The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R »^{(Archive.org • Wikiwix • Archive.is • Google • Que faire ?)}, European Archives of Psychiatry and Clinical Neuroscience, 1991 (PMID 1829000, DOI 10.1007/BF02189537), p. 258–265.

wiley.com

doi.wiley.com

(en) Janine Joyce et G Peter Herbison, « Reiki for depression and anxiety », Cochrane Database of Systematic Reviews,‎ 3 avril 2015 (DOI 10.1002/14651858.CD006833.pub2, lire en ligne, consulté le 7 mai 2021)
(en) Bonnie Meekums, Vicky Karkou et E Andrea Nelson, « Dance movement therapy for depression », Cochrane Database of Systematic Reviews,‎ 19 février 2015 (DOI 10.1002/14651858.CD009895.pub2, lire en ligne, consulté le 7 mai 2021)

media.wiley.com

(en) Caraveo-A. et Andrade L, « Epidemiology of major depressive episodes: Results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys », Int J Methods Psychiatr Res, vol. 12, n^o 1,‎ 2005, p. 3–21 (DOI 10.1002/mpr.138, lire en ligne).
(en) A.M. Gruenberg, « Classification of Depression: Research and Diagnostic Criteria: DSM-IV and ICD-10 » [PDF], wiley.com, 2005 (consulté le 30 octobre 2008).

willhall.net

The Icarus Project et Freedom Center, Guide Pour Décrocher des Médicaments Psychotropes En Réduisant Les Effets Nocifs, 2012 (lire en ligne [PDF])

wkhealth.com

meta.wkhealth.com

(en) Kellner CH et Bourgon LN, « Relapse of depression after ECT: a review », The journal of ECT, vol. 16, n^o 1,‎ 2000, p. 19–31 (DOI 10.1097/00124509-200003000-00003, lire en ligne).
(en) Petrides G et Frederikse M, « Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report », The journal of ECT, vol. 22, n^o 1,‎ 2006, p. 13–17 (PMID 16633200, DOI 10.1097/00124509-200603000-00003, lire en ligne).

zebrascrossing.org

wiki.zebrascrossing.org

Les hyperstimulabilités - la théorie de la Désintégration Positive - les surdoués